Rating History for Mereo BipPharma Group (MREO) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/23/2026 | Priyanka Grover | Downgrade | Neutral (Overweight) |
N/A (N/A) |
0.36 (0.32) |
-11.11% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/23/2026 | Priyanka Grover | Downgrade | Neutral (Overweight) |
N/A (N/A) |
0.36 (0.32) |
-11.11% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||